Skip to main content
Livermore
Livermore
ZHEN

Ellevest, Inc.

SEC CIK
0001644128
Latest filing
Aug 10, 2026

GSK holding history

GSK plc in every 13F filed by Ellevest, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GSK overviewAll 13F holders of GSKFull Q2 2026 holdings

Shares (Q2 2026)
16,672
Value
$871.9K
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of GSK by Ellevest, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202616,672$871.9K0.1%−745−4.3%ReducedHolders
Q1 202617,417$961.2K0.1%−754−4.1%ReducedHolders
Q4 202518,171$891.1K0.1%−1,210−6.2%ReducedHolders
Q3 202519,381$836.5K0.1%+180+0.9%AddedHolders
Q2 202519,201$737.3K0.1%−1,737−8.3%ReducedHolders
Q1 202520,938$811.1K0.1%+7,140+51.7%AddedHolders
Q4 202413,798$466.6K<0.1%−5,301−27.8%ReducedHolders
Q3 202419,099$780.8K<0.1%+1,137+6.3%AddedHolders
Q2 202417,962$691.5K<0.1%+3,616+25.2%AddedHolders
Q1 202414,346$615.0K<0.1%−1,211−7.8%ReducedHolders
Q4 202315,557$576.5K<0.1%+1,535+10.9%AddedHolders
Q3 202314,022$508.3K<0.1%−1,190−7.8%ReducedHolders
Q2 202315,212$542.2K<0.1%−523−3.3%ReducedHolders
Q1 202315,735$559.9K<0.1%+3,204+25.6%AddedHolders
Q4 202212,531$440.3K<0.1%+3,443+37.9%AddedHolders
Q3 20229,088$267.0K<0.1%−6,742−42.6%ReducedHolders
Q2 202215,830$689.0K0.1%+2,008+14.5%AddedHolders
Q1 202213,822$602.0K0.1%+2,129+18.2%AddedHolders
Q4 202111,693$516.0K<0.1%+2,143+22.4%AddedHolders
Q3 20219,550$365.0K<0.1%+7,277+320.1%AddedHolders
Q2 20212,273$91.0K<0.1%+958+72.9%AddedHolders
Q1 20211,315$47.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.